Journal of Liver

New insight on the Hepatitis B x antigen effector URG7

World Congress on Hepatitis

July 20-22, 2015 Orlando, Florida, USA

F Bisaccia, R Miglionico, A Ostuni, M Carmosino, M Pace and M F Armentano

Scientific Tracks Abstracts: J Liver

Abstract:

The up-regulated gene clone 7 (URG7) encodes a 99 amino acids protein induced by the hepatitis B virus antigen x (HBxAg). The first 74 amino acid residues are identical to the N-terminal residues of the multidrug-resistance protein 6 (MRP6). Studies carried out on cells transfected with HBxAg or URG7 have demonstrated that URG7 is able to prevent the TNF?- induced apoptosis by inhibiting the caspase 3 and 8 and activating the phosphoinositide 3-kinase and the ?-catenin pathways, thus favoring the survival of the infected cells. Anti-URG7 antibodies, found in the serum of HBV carriers, are considered pre-neoplastic markers for hepatocellular carcinoma (HCC). Recent studies have shown that the URG7 protein is glycosylated at the N-terminal region and is localized in the endoplasmic reticulum (ER) with the N-terminus in the ER lumen and the C-terminal in the cytoplasm. As HBV infection causes ER stress promoting the accumulation of unfolded protein aggregates, we investigated the role of the URG7 protein in the ER stress. Obtained results show that HepG2 cells over-expressing URG7 treated with tunicamycin show a specific pattern of ER stress markers expression suggesting that URG7 drives cells toward survival rather than apoptosis. This result suggests that URG7 can be a molecular target to promote apoptosis in HBV- infected cells.

Biography :

F Bisaccia completed his Degree in Chemistry and Pharmaceutical Technology in 1982. Currently he is a Director in the Department of Science at the University of Basilicata.